Skip to Main Content

Paper Details

Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.
Clin Cancer Res
76
2018
ASXL1, ATM, CBL, CHEK2, DNMT3A, DNMT3A mutations, JAK2, Patients, SF3B1, Solid Tumor, TET2, TP53, cancer, patient, patients, solid tumors, tumor
Author NameAffiliation
Jonathan S BergUniversity of North Carolina at Chapel Hill
Jonathan S BergLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Jonathan S BergUniversity of North Carolina at Chapel Hill
Markus BallMoffitt Cancer Center and Research Institute
Kelly L BoltonMemorial Sloan Kettering Cancer Center
Kelly L BoltonMemorial Sloan Kettering Cancer Center
Joel S ParkerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Joel S ParkerUniversity of North Carolina at Chapel Hill
Joel S ParkerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Joel S ParkerUniversity of North Carolina at Chapel Hill
David Neil HayesUniversity of North Carolina at Chapel Hill
David Neil HayesLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
David Neil HayesDivision of Medical Oncology at the University of Tennessee Health Science Center (UTHSC)
David Neil HayesUniversity of North Carolina at Chapel Hill
David Neil HayesLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
David Neil HayesDivision of Medical Oncology at the University of Tennessee Health Science Center (UTHSC)
  • 1 - 16

Datasets